P21WAF1 and tumourigenesis: 20 Years after

Current Opinion in Oncology

Volumn 25, Issue 1, 2013, Pages 52-58

  Warfel, Noel A ^a   El Deiry, Wafik S ^a  

^a PENN STATE CANCER INSTITUTE   (United States)

Author keywords

Cell cycle; Cyclin dependent kinase; p21; Wild type p53 activated fragment 1

Indexed keywords

CYCLIN DEPENDENT KINASE INHIBITOR 1; CYCLIN DEPENDENT KINASE INHIBITOR 1A; PROTEASOME; RNA;

APOPTOSIS; CANCER CELL; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL DIFFERENTIATION; CELL RENEWAL; CELL STIMULATION; CELL SURVIVAL; ENZYME DEGRADATION; ENZYME PHOSPHORYLATION; HUMAN; MOLECULAR GENETICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; RNA STABILITY; SENESCENCE; SIGNAL TRANSDUCTION; STEM CELL; TRANSCRIPTION REGULATION; UBIQUITINATION;

CELL CYCLE; CELL CYCLE PROTEINS; CELL TRANSFORMATION, NEOPLASTIC; CYCLIN-DEPENDENT KINASE INHIBITOR P21; GENE EXPRESSION REGULATION; GENES, P53; HUMANS; NEOPLASMS;

EID: 84871963013     PISSN: 10408746     EISSN: 1531703X     Source Type: Journal    
DOI: 10.1097/CCO.0b013e32835b639e     Document Type: Review

References (40)

1. el-Deiry WS, Tokino T, Velculescu VE, et al. Waf1, a potential mediator of p53 tumor suppression. Cell 1993; 75:817-825
2. Harper JW, Adami GR, Wei N, et al. The p21 cdk-interacting protein cip1 is a potent inhibitor of g1 cyclin-dependent kinases. Cell 1993; 75:805-816
3. Noda A, Ning Y, Venable SF, et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. Exp Cell Res 1994; 211: 90-98
4. Jiang H, Lin J, Su ZZ, et al. The melanoma differentiation-associated gene mda-6, which encodes the cyclin-dependent kinase inhibitor p21, is differentially expressed during growth, differentiation and progression in human melanoma cells. Oncogene 1995; 10:1855-1864
5. Narbonne-Reveau K, Lilly M. The cyclin-dependent kinase inhibitor dacapo promotes genomic stability during premeiotic s phase. Mol Biol Cell 2009; 20:1960-1969
6. Li JM, Datto MB, Shen X, et al. Sp1, but not sp3, functions to mediate promoter activation by tgf-beta through canonical sp1 binding sites. Nucleic Acids Res 1998; 26:2449-2456
7. Billon N, van Grunsven LA, Rudkin BB. The cdk inhibitor p21waf1/cip1 is induced through a p300-dependent mechanism during ngf-mediated neuronal differentiation of pc12 cells. Oncogene 1996; 13:2047-2054
8. Somasundaram K, Zhang H, Zeng YX, et al. Arrest of the cell cycle by the tumour-suppressor brca1 requires the cdk-inhibitor p21waf1/cip1. Nature 1997; 389:187-190
9. Mitchell KO, El-Deiry WS. Overexpression of c-myc inhibits p21waf1/cip1 expression and induces s-phase entry in 12-o-tetradecanoylphorbol-13- acetate (tpa)-sensitive human cancer cells. Cell Growth Differ 1999; 10: 223-230
10. Kitaura H, Shinshi M, Uchikoshi Y, et al. Reciprocal regulation via protein-protein interaction between c-myc and p21(cip1/waf1/sdi1) in DNA replication and transcription. J Biol Chem 2000; 275:10477-10483
11. Gartel AL, Tyner AL. Transcriptional regulation of the p21((waf1/cip1)) gene. Exp Cell Res 1999; 246:280-289
12. Nie M, Balda MS, Matter K. Stress- and rho-activated zo-1-associated nucleic acid binding protein binding to p21 mRNA mediates stabilization, translation, and cell survival. Proc Natl Acad Sci U S A 2012; 109:10897-10902
13. Jascur T, Brickner H, Salles-Passador I, et al. Regulation of p21(waf1/cip1) stability by wisp39, a hsp90 binding tpr protein. Mol Cell 2005; 17:237-249
14. Abbas T, Sivaprasad U, Terai K, et al. Pcna-dependent regulation of p21 ubiquitylation and degradation via the crl4cdt2 ubiquitin ligase complex. Genes Dev 2008; 22:2496-2506
15. Amador V, Ge S, Santamaria PG, et al. Apc/c(cdc20) controls the ubiquitinmediated degradation of p21 in prometaphase. Mol Cell 2007; 27:462-473
16. Starostina NG, Simpliciano JM, McGuirk MA, Kipreos ET. Crl2(lrr-1) targets a cdk inhibitor for cell cycle control in c. Elegans and actin-based motility regulation in human cells. Dev Cell 2010; 19:753-764
17. Jin Y, Lee H, Zeng SX, et al. Mdm2 promotes p21waf1/cip1 proteasomal turnover independently of ubiquitylation. Embo J 2003; 22:6365-6377
18. Zhou BP, Liao Y, Xia W, et al. Cytoplasmic localization of p21cip1/waf1 by akt-induced phosphorylation in her-2/neu-overexpressing cells. Nat Cell Biol 2001; 3:245-252
19. Rossig L, Jadidi AS, Urbich C, et al. Akt-dependent phosphorylation of p21(cip1) regulates pcna binding and proliferation of endothelial cells. Mol Cell Biol 2001; 21:5644-5657
20. Cornils H, Kohler RS, Hergovich A, Hemmings BA. Human ndr kinases control g(1)/s cell cycle transition by directly regulating p21 stability. Mol Cell Biol 2011; 31:1382-1395
21. Chen J, Saha P, Kornbluth S, et al. Cyclin-binding motifs are essential for the function of p21cip1. Mol Cell Biol 1996; 16:4673-4682
22. Luo Y, Hurwitz J, Massague J. Cell-cycle inhibition by independent cdk and pcna binding domains in p21cip1. Nature 1995; 375:159-161
23. Delavaine L, La Thangue NB. Control of e2f activity by p21waf1/cip1. Oncogene 1999; 18:5381-5392
24. Coqueret O, Gascan H. Functional interaction of stat3 transcription factor with the cell cycle inhibitor p21waf1/cip1/sdi1. J Biol Chem 2000; 275:18794-18800
25. Cheng M, Olivier P, Diehl JA, et al. The p21(cip1) and p27(kip1) cdk 'inhibitors' are essential activators of cyclin d-dependent kinases in murine fibroblasts. Embo J 1999; 18:1571-1583
26. Dash BC, El-Deiry WS. Phosphorylation of p21 in g2/m promotes cyclin b-cdc2 kinase activity. Mol Cell Biol 2005; 25:3364-3387
27. Han Z, Wei W, Dunaway S, et al. Role of p21 in apoptosis and senescence of human colon cancer cells treated with camptothecin. J Biol Chem 2002; 277:17154-17160
28. Waldman T, Kinzler KW, Vogelstein B. P21 is necessary for the p53-mediated g1 arrest in human cancer cells. Cancer Res 1995; 55:5187-5190
29. Asada M, Yamada T, Ichijo H, et al. Apoptosis inhibitory activity of cytoplasmic p21(cip1/waf1) in monocytic differentiation. Embo J 1999; 18:1223- 1234
30. Jin YH, Yoo KJ, Lee YH, Lee SK. Caspase 3-mediated cleavage of p21waf1/ cip1 associated with the cyclin a-cyclin-dependent kinase 2 complex is a prerequisite for apoptosis in sk-hep-1 cells. J Biol Chem 2000; 275:30256- 30263
31. Liu M, Lee MH, Cohen M, et al. Transcriptional activation of the cdk inhibitor p21 by vitamin d3 leads to the induced differentiation of the myelomonocytic cell line u937. Genes Dev 1996; 10:142-153
32. Paramio JM, Segrelles C, Ruiz S, et al. The ink4a/arf tumor suppressors cooperate with p21cip1/waf in the processes of mouse epidermal differentiation, senescence, and carcinogenesis. J Biol Chem 2001; 276:44203- 44211
33. Cheng T, Rodrigues N, Shen H, et al. Hematopoietic stem cell quiescence maintained by p21cip1/waf1. Science 2000; 287:1804-1808
34. Viale A, De Franco F, Orleth A, et al. Cell-cycle restriction limits DNA damage and maintains self-renewal of leukaemia stem cells. Nature 2009; 457:51- 56
35. Liu M, Casimiro MC, Wang C, et al. P21cip1 attenuates ras- and c-mycdependent breast tumor epithelial mesenchymal transition and cancer stem cell-like gene expression in vivo. Proc Natl Acad Sci U S A 2009; 106: 19035-19039
36. Capparelli C, Chiavarina B, Whitaker-Menezes D, et al. Cdk inhibitors (p16/p19/p21) induce senescence and autophagy in cancer-associated fibroblasts, 'fueling' tumor growth via paracrine interactions, without an
37. Deng C, Zhang P, Harper JW, et al. Mice lacking p21cip1/waf1 undergo normal development, but are defective in g1 checkpoint control. Cell 1995; 82:675-684
38. Jackson RJ, Engelman RW, Coppola D, et al. P21cip1 nullizygosity increases tumor metastasis in irradiated mice. Cancer Res 2003; 63:3021-3025
39. Abbas T, Dutta A. P21 in cancer: Intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400-414
40. Lee S, Helfman DM. Cytoplasmic p21cip1 is involved in ras-induced inhibition of the rock/limk/cofilin pathway. J Biol Chem 2004; 279:1885-1891.